共 42 条
[1]
THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS
[J].
ARTHRITIS AND RHEUMATISM,
1988, 31 (03)
:315-324
[2]
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
[J].
ARTHRITIS AND RHEUMATISM,
2005, 52 (07)
:1986-1992
[4]
Tumor necrosis factor antagonist therapy and lymphoma development - Twenty-six cases reported to the Food and Drug Administration
[J].
ARTHRITIS AND RHEUMATISM,
2002, 46 (12)
:3151-3158
[5]
Bureau of National Health Insurance Department of Health Executive Yuan, 2011, NAT HLTH INS TAIW 20
[6]
Cohen J., 1988, Statistical power analysis for the behavioral sciences, VSecond
[7]
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists
[J].
ARTHRITIS AND RHEUMATISM,
2007, 56 (04)
:1125-1133
[8]
Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis -: Lessons from interpreting data from observational studies
[J].
ARTHRITIS AND RHEUMATISM,
2007, 56 (09)
:2896-2904
[9]
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy - Results from the British Society for Rheumatology Biologics Register
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (08)
:2368-2376